MICHAEL O'BRIEN: Open Payments
NPI 1295082725 · BEAVER, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$559 in 18 payments from 3 companies in 2025. Trend: 2023 $1,937 · 2024 $972 · 2025 $559
Food & beverage: $559
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 14 | $380 |
| Neurocrine BioSciences, Inc. | 3 | $164 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
Products named: AUSTEDO XR, INGREZZA, REXULTI.
Industry payments across PA — which companies pay providers there.
